Spotlight on the Cancer Research UK Clinical Trials Unit (CRCTU) at the University of Birmingham
The Cancer Research UK Clinical Trials Unit (CRCTU) forms part of the School of Cancer Sciences at the University and is one of the largest cancer trials units in the UK and has been in existence for more than 30 years. They are one of three trials units at the University that form the Birmingham Centre for Clinical Trials and also form an integral part of the Birmingham Experimental Cancer Medicine Centre. The unit receives core funding from Cancer Research UK.
They specialise in the design, conduct and analysis of all phases of trials, from phase I, largely concerned with the safety of treatments, all the way through to phase IV cancer clinical trials, looking at the long term risks and benefits of treatments.We work with a wide range of investigators nationwide and internationally in a number of specialist areas including Breast cancer, Lung cancer, Paediatric cancer, Skin cancer and Urological cancer.
The CRCTU has experience in trials involving pharmaceutically active substances, the testing of new treatments on human subjects for the first time, radiotherapy, devices, surgery, allogeneic stem cell transplantation, gene therapy, immunotherapy and biomarker discovery and development.
You can find out more by reading their blog and over the next five days they are going to share some of the exciting clinical research being done at the unit. They will also be touching on related topical events throughout the week.